| Symbol | ATAI |
|---|---|
| Name | ATAIBECKLEY INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | C/O ATAI LIFE SCIENCES US, INC., NEW YORK, NY 10119 |
| Telephone | 1 929 207 2670 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002081043 |
| Description | None |
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
Read moreNew Form SCHEDULE 13D/A - AtaiBeckley Inc. <b>Filed:</b> 2026-07-17 <b>AccNo:</b> 0001193125-26-308002 <b>Size:</b> 20 KB
Read more$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of AtaiBeckley Inc. (NASDAQ: ATAI)
Read moreNew Form DEFA14A - AtaiBeckley Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001140361-26-028705 <b>Size:</b> 77 KB
Read moreNew Form DEFA14A - AtaiBeckley Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001140361-26-028710 <b>Size:</b> 43 KB
Read moreNew Form DEFA14A - AtaiBeckley Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001140361-26-028706 <b>Size:</b> 21 KB
Read moreNew Form DEFA14A - AtaiBeckley Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001140361-26-028707 <b>Size:</b> 22 KB
Read moreNew Form DEFA14A - AtaiBeckley Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001140361-26-028708 <b>Size:</b> 19 KB
Read moreNew Form DEFA14A - AtaiBeckley Inc. <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001140361-26-028709 <b>Size:</b> 23 KB
Read moreShareholder Alert: Ademi LLP investigates whether AtaiBeckley Inc. is obtaining a Fair Price for Public Shareholders
Read more